Clinical and physiological evaluation of mucolytic agents nebulized with isoproterenol: 10% N-acetylcysteine versus 10% 2-mercaptoethane sulphonate
- 1 November 1970
- Vol. 25 (6) , 737-743
- https://doi.org/10.1136/thx.25.6.737
Abstract
In a controlled five-week cross-over study in 12 patients with chronic bronchitis, the effects of nebulized 10% N-acetylcysteine plus isoproterenol were compared with a new drug, sodium 2-mercaptoethane sulphonate, in 10% concentration also nebulized with isoproterenol. Both combinations were compared with a control aerosol of saline and a second control aerosol of saline plus isoproterenol. Both 10% 2-mercaptoethane sulphonate and 10% N-acetylcysteine were highly effective in thinning mucoid, mucopurulent or purulent sputum. Subjective improvement in these patients, however, was related to the isoproterenol rather than to the mucolytic agents. When nebulized with isoproterenol, neither mucolytic agent was associated with bronchospasm in any patient. Physical findings, spirometric values, and sputum volume were unaffected by these mucolytic agents.Keywords
This publication has 6 references indexed in Scilit:
- Sputum liquefying agents: a comparative in vitro evaluation.1969
- Nebulization of N-Acetylcysteine Combined with a Bronchodilator in Patients with Chronic BronchitisDiseases of the Chest, 1968
- An evaluation of the effect of nebulized N-acetylcysteine on sputum consistencyJournal of Allergy, 1967
- Evaluation of changes in sputum consistency with a new instrument.Published by Elsevier ,1966
- Iatrogenic Bronchospasm Occurring during Clinical Trials of a New Mucolytic Agent, AcetylcysteineDiseases of the Chest, 1964
- Deoxyribonuclease in the Treatment of Purulent BronchitisThorax, 1953